By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

OncoMed Pharmaceuticals, Inc. 

800 Chesapeake Drive

Redwood City  California  94063  U.S.A.
Phone: 650-995-8200 Fax: 650-298-8600


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





Company News
OncoMed Pharmaceuticals, Inc. (OMED) To Present Data On Multiple Anti-Cancer Stem Cell Candidates At The American Association for Cancer Research Meeting 3/19/2015 7:48:33 AM
OncoMed Pharmaceuticals, Inc. (OMED) Reports Full Year And Fourth Quarter 2014 Financial Results And Recent Highlights 3/13/2015 7:21:41 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Report Full Year And Fourth Quarter 2014 Financial Results On Thursday, March 12, 2015 3/3/2015 8:27:19 AM
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Dosing In Phase 2 Clinical Trial Of Demcizumab For The Treatment Of Non-Small Cell Lung Cancer 2/4/2015 7:36:32 AM
FDA Grants Orphan Drug Designations To OncoMed Pharmaceuticals, Inc. (OMED)'s Tarextumab For The Treatment Of Pancreatic And Small Cell Lung Cancer 1/29/2015 7:56:21 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present At The Biotechnology Industry Organization (BIO) CEO And Investor And Leerink Global Healthcare Conferences In February 1/28/2015 8:02:57 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Final Phase 1b Safety, Efficacy And Biomarker Data For Tarextumab In Pancreatic Cancer At The 2015 Gastrointestinal Cancer Symposium 1/19/2015 7:06:38 AM
OncoMed Pharmaceuticals, Inc. (OMED) Enrolls First Biomarker-Selected Patient In Expansion Stage Of Anti-Notch1 Phase 1a Trial In Solid Tumors 1/15/2015 7:06:09 AM
OncoMed Pharmaceuticals, Inc. (OMED) To Present Clinical Data And Biomarker Analysis For Tarextumab At The 2015 Gastrointestinal Cancer Symposium 1/13/2015 7:01:13 AM
OncoMed Pharmaceuticals, Inc. (OMED) Pre-Announces 2014 Year-End Cash Balance And Provides 2015 Guidance 1/12/2015 7:27:11 AM
12345678910...
//-->